GNG7 and ADCY1 may be an oncogene that regulated tumorigenesis and development through pathways in cancer and could be used as a biomarker of the diagnostic and prognostic value of PAAD. This evidence concerns the gene GNG7 and pancreatic adenocarcinoma.